Showing 1,401 - 1,420 results of 102,833 for search '(( 5 ((mg decrease) OR (a decrease)) ) OR ( 50 ((mean decrease) OR (nn decrease)) ))', query time: 1.46s Refine Results
  1. 1401
  2. 1402
  3. 1403

    Decreased Expression of TGR5 in Vogt-Koyanagi-Harada (VKH) Disease by Jinglu Yang (6391913)

    Published 2019
    “…</p> <p><i>Results</i>: A decreased expression of TGR5 in M1 macrophages was observed in active VKH patients as compared with normal controls. …”
  4. 1404
  5. 1405
  6. 1406
  7. 1407
  8. 1408
  9. 1409
  10. 1410
  11. 1411
  12. 1412
  13. 1413
  14. 1414
  15. 1415

    Decreased clearance of IgAN patient IgA by CD89-expressing Kupffer cells. by Lijun Xu (195394)

    Published 2016
    “…(B) sCD89-IgA complexes in cell supernatant of (A) were detected by ELISA using A3 and anti-mouse IgA mAb, using 1 μg/mL human IgA binding to 5 μg/mL recCD89 as an internal control. …”
  16. 1416

    vFLIP and vCyclin decrease SMAD2 protein expression and desensitize TGF-β signaling. by Hong Seok Choi (121525)

    Published 2015
    “…<p>(A) SMAD2 expression was drastically decreased upon the expression of vFLIP or vCyclin in SLK cells. …”
  17. 1417
  18. 1418

    Dose-dependent increase in NREM sleep and decrease in wakefulness by <i>p</i>.<i>o</i>. administration of TEG in mice. by Mahesh K. Kaushik (3753871)

    Published 2017
    “…<p>(A, B) Typical examples of EEG delta power (0.5–4 Hz), EMG integral, and hypnograms of a mouse after <i>p</i>.…”
  19. 1419

    GluN2A(D731N) enhances sensitivity to endogenous proton and zinc ions. by Kai Gao (120150)

    Published 2017
    “…Di-heteromeric (h2A-D731N), one-copy and two-copy mutant tri-heteromeric (D731N/2A and D731N/D731N) receptors show a decreased current ratio, indicating enhanced proton sensitivity. …”
  20. 1420

    Mg-supplementation attenuated lipogenic and oxidative/nitrosative gene expression caused by Combination Antiretroviral Therapy (cART) in HIV-1-transgenic rats by Lama ElZohary (6250859)

    Published 2019
    “…<div><p>We determined if HIV-1 expression in transgenic (HIV-1-Tg) rats enhanced hepatic genomic changes related to oxidative/nitrosative stress and lipogenesis during cART-treatment, and assessed effects of Mg-supplementation. A clinically used cART (atazanavir-ritonavir+Truvada) was given orally to control and HIV-1-Tg rats (18 weeks) with normal or 6-fold dietary-Mg. …”